I thought we read just last week that remdesavir didn’t pan out and now it’s the cat’s meow. Are you assuming a combo will be preferred no matter which drugs show effectiveness?
“My bet is If Brilacidin aces the RBL Coronovirus infected human respiratory epithelial cells we will be in a combination trial with Remdesivir in a few months. “
Market Data 
Markets 
AI
